FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sigrid Klaar

Research Profile

Disorders

Breast Neoplasms

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Genes & Molecular Sequences

Genes, p53

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
J Bergqvist; John Ohd; Johanna Smeds; Sigrid Klaar; J Isola; Hans Nordgren; Göran Elmberger; H Hellborg; J Bjohle; Anna-Lena Borg; Lambert Skoog; Jonas Bergh
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome.
Kristian Wennmalm; Stefano Calza; Alexander Ploner; Per Hall; Judith Bjöhle; Sigrid Klaar; Johanna Smeds; Yudi Pawitan; Jonas Bergh
Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes.
Magali Olivier; Anita Langerød; Patrizia Carrieri; Jonas Bergh; Sigrid Klaar; Jorunn Eyfjord; Charles Theillet; Carmen Rodriguez; Rosette Lidereau; Ivan Bièche; Jennifer Varley; Yves Bignon; Nancy Uhrhammer; Robert Winqvist; Arja Jukkola-Vuorinen; Dieter Niederacher; Shunsuke Kato; Chikashi Ishioka; Pierre Hainaut; Anne-Lise Børresen-Dale
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sigrid Klaar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: J Bergqvist; John Ohd; Johanna Smeds; Sigrid Klaar; J Isola; Hans Nordgren; Göran Elmberger; H Hellborg; J Bjohle; Anna-Lena Borg; Lambert Skoog; Jonas Bergh
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):845-50.
2007: Kristian Wennmalm; Stefano Calza; Alexander Ploner; Per Hall; Judith Bjöhle; Sigrid Klaar; Johanna Smeds; Yudi Pawitan; Jonas Bergh
Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes.
Genes, chromosomes & cancer 2007;46(1):87-97.
2006: Magali Olivier; Anita Langerød; Patrizia Carrieri; Jonas Bergh; Sigrid Klaar; Jorunn Eyfjord; Charles Theillet; Carmen Rodriguez; Rosette Lidereau; Ivan Bièche; Jennifer Varley; Yves Bignon; Nancy Uhrhammer; Robert Winqvist; Arja Jukkola-Vuorinen; Dieter Niederacher; Shunsuke Kato; Chikashi Ishioka; Pierre Hainaut; Anne-Lise Børresen-Dale
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1157-67.
2006: Stefano Calza; Per Hall; Gert Auer; Judith Bjöhle; Sigrid Klaar; Ulrike Kronenwett; Edison Liu; Lance Miller; Alexander Ploner; Johanna Smeds; Jonas Bergh; Yudi Pawitan
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.
Breast cancer research : BCR 2006;8(4):R34.
2005: Lance D Miller; Johanna Smeds; joshy george; Vinsensius B Vega; Liza Vergara; Alexander Ploner; Yudi Pawitan; Per Hall; Sigrid Klaar; Edison Liu; Jonas Bergh
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(38):13550-5.
2005: J Andersson; L Larsson; Sigrid Klaar; Lars Holmberg; J Nilsson; M Inganäs; G Carlsson; John Ohd; C-M Rudenstam; B Gustavsson; Jonas Bergh
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):743-8.
2005: Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.
Breast cancer research : BCR 2005;7(6):R953-64.
2005: Johanna Smeds; Lance D Miller; Judith Bjöhle; Per Hall; Sigrid Klaar; Edison Liu; Yudi Pawitan; Alexander Ploner; Jonas Bergh
Gene profile and response to treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 2():ii195-202.
2004: Barbro Linderholm; Eva Karlsson; Sigrid Klaar; Thomas Lindahl; Anna-Lena Borg; Göran Elmberger; Jonas Bergh
Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers.
European journal of cancer (Oxford, England : 1990) 2004;40(16):2417-23.
2004: Thomas Lindahl; Göran Landberg; Johan Ahlgren; Hans Nordgren; Torbjörn Norberg; Sigrid Klaar; Lars Holmberg; Jonas Bergh
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.
Carcinogenesis 2004;25(3):375-80.
2004: Paula Poikonen; Johanna Sjöström; Sigrid Klaar; Lena Tennvall Nittby; Helgi Sigurdsson; Ebbe Lindegaard Madsen; Heikki Joensuu; Carl Blomqvist
Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel.
Acta oncologica (Stockholm, Sweden) 2004;43(2):190-5.
2002: Jenny Andersson; Barbro Linderholm; Gudrun Greim; Birgitta Lindh; Henrik Lindman; Jan Tennvall; Lena Tennvall-Nittby; Dagny Pettersson-Sköld; Asgerdur Sverrisdottir; Martin Söderberg; Sigrid Klaar; Jonas Bergh
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden.
Acta oncologica (Stockholm, Sweden) 2002;41(3):276-81.
2001: Torbjörn Norberg; Sigrid Klaar; G Kärf; Hans Nordgren; L Holmberg; Jonas Bergh
Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.
Cancer research 2001;61(22):8317-21.
2001: Torbjörn Norberg; Sigrid Klaar; L Lindqvist; T Lindahl; Johan Ahlgren; Jonas Bergh
Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers.
Clinical chemistry 2001;47(5):821-8.
2001: Barbro Linderholm; Thomas Lindahl; L Holmberg; Sigrid Klaar; Johan Lennerstrand; Roger Henriksson; Jonas Bergh
The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
Cancer research 2001;61(5):2256-60.
2000: T Lindahl; G Engel; Johan Ahlgren; Sigrid Klaar; Judith Bjöhle; Henrik Lindman; Jenny Andersson; E von Schoultz; Jonas Bergh
Can axillary dissection be avoided by improved molecular biological diagnosis?
Acta oncologica (Stockholm, Sweden) 2000;39(3):319-26.